OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI [TechCrunch]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: TechCrunch
million cases in 2022, according to the World Health Organization. Cancer survivors globally reached 53.5 million, and the reoccurrence rate of the disease varies between 15 and 100%, depending on the cancer type and stage and each patient's situation. Despite this, the world currently lacks effective solutions for diagnoses to help curb recurrence. Enter OneCell Diagnostics , a genomics-based startup in precision oncology, that aims to help cancer survivors limit reoccurrence instances through its proprietary cell biopsy technology. The startup, which has served nearly 10,000 patients in India and is looking to replicate its early Indian success in the U.S., has developed its in-house blood-based biopsy testing that helps detect cancer's reoccurrence through circulating tumor cells. This is unlike the widely used cancer detection methods, including PET CT scan, MRI, and tissue-based diagnosis. OneCell has secured an IP to capture and isolate the circulating tumor cell from a 10
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care [Yahoo! Finance]Yahoo! Finance
- Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer CareBusiness Wire
- COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics [Yahoo! Finance]Yahoo! Finance
- COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI AnalyticsBusiness Wire
- Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 11/6/24 - Beat
GH
Sec Filings
- 12/19/24 - Form 4
- 12/18/24 - Form 144
- 12/16/24 - Form 4
- GH's page on the SEC website